A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer

OBJECTIVE: Although many curative treatments are being applied in the clinic, a significant number of patients with liver hepatocellular carcinoma (LIHC) suffer from drug resistance. The tumour microenvironment (TME) has been found to be closely associated with resistance, suggesting that identifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Mingyi, Jiang, Longyang, Wei, Qian, Yu, Lifeng, Chen, Lianze, Wang, Yan, Hu, Baohui, Qian, Ping, Zhang, Ming, Zhou, Chenyi, Li, Zinan, Wei, Minjie, Zhao, Lin, Han, Jiali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543032/
https://www.ncbi.nlm.nih.gov/pubmed/34707365
http://dx.doi.org/10.2147/OTT.S326784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543032/
https://www.ncbi.nlm.nih.gov/pubmed/34707365
http://dx.doi.org/10.2147/OTT.S326784

Ejemplares similares